Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced that Edward Lanphier, Sangamo’s president and CEO, presented an overview of the state of the Advanced Therapies Industry on Thursday, March 12, 2015 at the Alliance for Regenerative Medicine’s (ARM) 5th Annual Advanced Therapies Summit, being held in Paris, France. On Monday shares of Sangamo Biosciences Inc. (NASDAQ:SGMO) closed at $17.38. Company’s sales growth for last 5 years was 15.60%.
On March 09, Opexa Therapeutics, Inc. (NASDAQ:OPXA) announced that it has amended its option and license agreement with Merck Serono (a division of Merck, Darmstadt, Germany) and will receive a $3 million payment. The payment provides support for the ongoing Phase 2b clinical study of Tcelna® (imilecleucel-T), Opexa’s personalized immunotherapy in development for patients with Secondary Progressive MS (SPMS), as well as the preparation and planning of potential Phase 3 studies. Opexa Therapeutics, Inc. (NASDAQ:OPXA) in last trading activity advanced 7.64% to close at $0.69. Company weekly performance is -9.32% while its quarterly performance stands at -9.24%. Opexa Therapeutics, Inc. (NASDAQ:OPXA) is -68.69% away from its 52 week high.
On Mar 9, EVINE Live Inc. (NASDAQ: EVLV), announced that it has increased the size of its credit facility to $90 million from $75 million. The credit facility is with EVINE’s existing bank PNC Bank, National Association, (NASDAQ: PNC) and in conjunction with a new partner, The PrivateBank, a subsidiary of PrivateBancorp, Inc. (NASDAQ: PVTB). The facility is comprised of a $75 million revolving credit line and a $15 million term loan. PrivateBancorp, Inc. (NASDAQ:PVTB) has 2.00% insider ownership while its institutional ownership stands at 95.70%. In last trading activity company’s stock closed at $35.91.
United Continental Holdings (NYSE:UAL) has been given a “B” credit rating by Morningstar. The investment research firm’s “B” rating suggests that the company is a high default risk. They also gave their stock a three star rating. On last trading day United Continental Holdings, Inc. (NYSE:UAL) advanced 0.52% to close at $67.92. Its volatility for the week is 2.50% while volatility for the month is 3.32%. UAL’s sales growth for past 5 years was 19.00% and its EPS growth for past 5 years was 21.80%. United Continental Holdings, Inc. (NYSE:UAL) monthly performance is 0.86%.